ALLOGRAFT-REJECTION IS ASSOCIATED WITH A TH2-DOMINANT CYTOKINE PROFILE

被引：0

作者：

MARTINEZ, OM ^{[1
]}

LANG, T ^{[1
]}

VILLANUEVA, JC ^{[1
]}

ESQUIVEL, CO ^{[1
]}

SO, S ^{[1
]}

KRAMS, SM ^{[1
]}

机构：

[1] CALIF PACIFIC MED CTR,TRANSPLANTAT IMMUNOBIOL LAB,SAN FRANCISCO,CA 94115

来源：

FASEB JOURNAL | 1995年 / 9卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A497 / A497

页数：1

共 50 条

[31] ENDOTHELIAL-CELL ACTIVATION AND CYTOKINE EXPRESSION DURING ACUTE HUMAN CARDIAC ALLOGRAFT-REJECTION [J].

SALOM, R ;

MAGUIRE, J ;

ESMORE, D ;

HANCOCK, W .

TRANSPLANTATION PROCEEDINGS, 1995, 27 (03) :2164-2165

[32] T-LYMPHOCYTE AND CYTOKINE-DIRECTED STRATEGIES FOR INHIBITING SKIN ALLOGRAFT-REJECTION IN MICE [J].

VOSSEN, ACTM ;

TIBBE, GJM ;

BENNER, R ;

SAVELKOUL, HFJ .

TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) :380-382

[33] URINE CYTOLOGIC PROFILE IN RENAL-ALLOGRAFT RECIPIENTS DETERMINED BY MONOCLONAL-ANTIBODIES - DIAGNOSIS OF ALLOGRAFT-REJECTION [J].

SEGASOTHY, M ;

BIRCH, DF ;

FAIRLEY, KF ;

KINCAIDSMITH, P .

TRANSPLANTATION, 1989, 47 (03) :482-487

[34] HEPATIC PRESERVATION WITH UNIVERSITY-OF-WISCONSIN SOLUTION IS ASSOCIATED WITH REDUCED ALLOGRAFT-REJECTION [J].

CAMPBELL, DA ;

MERION, RM ;

HAM, JM ;

LUCEY, MR ;

HENLEY, KS ;

TURCOTTE, G .

TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) :1547-1549

[35] IL-2 ACTIVATED KILLER-CELL ACTIVITY IS ASSOCIATED WITH THE EARLY PHASE OF ALLOGRAFT-REJECTION [J].

KAMHOLZ, S ;

ROSLIN, M ;

MONDRAGON, M ;

COONS, M ;

TRANBAUGH, R ;

STRASHUN, A ;

MANJONEY, D ;

NORIN, A .

TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) :597-598

[36] INDUCTION OF ACUTE CORNEAL ALLOGRAFT-REJECTION BY ALPHA-2 INTERFERON [J].

JACOBS, AD ;

LEVENSON, JE ;

GOLDE, DW .

AMERICAN JOURNAL OF MEDICINE, 1987, 82 (01) :181-182

[37] EXPRESSION OF 2 SERINE ESTERASE GENES DURING AN ALLOGRAFT-REJECTION IN THE MOUSE [J].

MUELLER, C ;

GERSHENFELD, HK ;

LOBE, CG ;

OKADA, CY ;

BLEACKLEY, RC ;

WEISSMAN, IL .

TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) :251-253

[38] ORAL, BUT NOT INTRAVENOUS, ALLOANTIGEN PREVENTS ACCELERATED ALLOGRAFT-REJECTION BY SELECTIVE INTRAGRAFT TH2 CELL ACTIVATION [J].

HANCOCK, WW ;

SAYEGH, MH ;

KWOK, CA ;

WEINER, HL ;

CARPENTER, CB .

TRANSPLANTATION, 1993, 55 (05) :1112-1118

[39] INTERLEUKIN-2 RECEPTOR IN RAT-HEART ALLOGRAFT-REJECTION [J].

BOUCHOT, O ;

ANEGON, I ;

ROMANIUK, A ;

JACQUES, Y ;

PAINEAU, J ;

SOULILLOU, JP .

TRANSPLANTATION, 1989, 48 (06) :918-922

[40] ANALYSIS OF SERUM CYTOKINE LEVELS IN HEART-TRANSPLANT RECIPIENTS - CORRELATION WITH STAGE OF ALLOGRAFT-REJECTION (AR) [J].

JORDAN, S ;

TRENTO, A ;

TOYODA, M ;

CZER, L ;

GALFAYAN, K ;

DOAN, D ;

BLANCHE, C ;

FISHBEIN, M ;

MATLOFF, J .

CLINICAL RESEARCH, 1991, 39 (01) :A47-A47

← 1 2 3 4 5 →